UV Germi SA

ENXTPA:ALUVI Stock Report

Market Cap: €8.6m

UV Germi Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Andres Bordas

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure10.7yrs
CEO ownershipn/a
Management average tenure6.1yrs
Board average tenure8.4yrs

Recent management updates

Recent updates

UV Germi (EPA:ALUVI) Might Have The Makings Of A Multi-Bagger

Dec 13
UV Germi (EPA:ALUVI) Might Have The Makings Of A Multi-Bagger

UV Germi SA's (EPA:ALUVI) Business Is Trailing The Market But Its Shares Aren't

Aug 13
UV Germi SA's (EPA:ALUVI) Business Is Trailing The Market But Its Shares Aren't

We Like These Underlying Return On Capital Trends At UV Germi (EPA:ALUVI)

Apr 25
We Like These Underlying Return On Capital Trends At UV Germi (EPA:ALUVI)

Here's Why I Think UV Germi (EPA:ALUVI) Might Deserve Your Attention Today

Oct 23
Here's Why I Think UV Germi (EPA:ALUVI) Might Deserve Your Attention Today

Some Confidence Is Lacking In UV Germi SA's (EPA:ALUVI) P/E

Sep 07
Some Confidence Is Lacking In UV Germi SA's (EPA:ALUVI) P/E

CEO Compensation Analysis

How has Andres Bordas's remuneration changed compared to UV Germi's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

€198k

Mar 31 2024n/an/a

€244k

Dec 31 2023n/an/a

€290k

Sep 30 2023n/an/a

€311k

Jun 30 2023n/an/a

€331k

Mar 31 2023n/an/a

€199k

Dec 31 2022n/an/a

€66k

Sep 30 2022n/an/a

-€209k

Jun 30 2022n/an/a

-€483k

Mar 31 2022n/an/a

-€676k

Dec 31 2021n/an/a

-€870k

Sep 30 2021n/an/a

-€314k

Jun 30 2021n/an/a

€241k

Mar 31 2021n/an/a

€326k

Dec 31 2020€88k€83k

€410k

Sep 30 2020n/an/a

€327k

Jun 30 2020n/an/a

€244k

Mar 31 2020n/an/a

€170k

Dec 31 2019€88k€83k

€96k

Sep 30 2019n/an/a

-€62k

Jun 30 2019n/an/a

-€220k

Mar 31 2019n/an/a

-€291k

Dec 31 2018€93k€88k

-€361k

Sep 30 2018n/an/a

-€356k

Jun 30 2018n/an/a

-€351k

Mar 31 2018n/an/a

-€269k

Dec 31 2017€92k€86k

-€186k

Compensation vs Market: Insufficient data to establish whether Andres's total compensation is reasonable compared to companies of similar size in the French market.

Compensation vs Earnings: Andres's compensation has been consistent with company performance over the past year.

CEO

Andres Bordas

10.7yrs

Tenure

€88,378

Compensation

Mr. Andres Bordas has served as the Chairman of the Board and Director of UV Germi, Société anonyme since April 16, 2014 and Chief Executive Officer at UV GERMI, Société anonyme since April 17, 2014.

Leadership Team

NamePositionTenureCompensationOwnership
Andres Bordas
Chairman & CEO10.7yrs€88.38kno data
Corinne Chansiaud
Financial Controller & Directorno data€44.95kno data
Willy Fortunato
Deputy CEO3.9yrsno datano data
Sandrine Bordas
Deputy CEO & Director6.1yrsno datano data

6.1yrs

Average Tenure

Experienced Management: ALUVI's management team is seasoned and experienced (6.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Andres Bordas
Chairman & CEO10.7yrs€88.38kno data
Corinne Chansiaud
Financial Controller & Director10.7yrs€44.95kno data
Willy Fortunato
Deputy CEO3.9yrsno datano data
Sandrine Bordas
Deputy CEO & Director6.1yrsno datano data
Julien Pourquery
Director1.3yrsno datano data
Bernadette Bordas
Director10.7yrsno datano data

8.4yrs

Average Tenure

Experienced Board: ALUVI's board of directors are considered experienced (8.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 00:17
End of Day Share Price 2024/12/30 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

UV Germi SA is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charles-Louis PlanadeTPICAP Midcap
Valerie Ducreux DieppeTPICAP Midcap
Christel ClemeTPICAP Midcap